Diaceutics (DXRX) Stock Statistics & Valuation Metrics

Diaceutics has a market cap or net worth of £163.62M. The enterprise value is 117.62 p.

Diaceutics has 85,154,360 shares outstanding. The number of shares has decreased by -2.65% in one year.

Diaceutics’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.26%.

The current PE Ratio of Diaceutics is ―. Diaceutics’s PEG ratio is -11.04.

In the last 12 months, Diaceutics had revenue of 38.44M and earned 97.00K in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was 4.12M and capital expenditures -37.00K, giving a free cash flow of 4.08M billion.

Diaceutics pays an annual dividend of ―, resulting in a dividend yield of ―

Diaceutics upcoming earnings date is Mar 15, 2027, Before Open (Confirmed).

Diaceutics as a current ratio of 3.43, with Debt / Equity ratio of 5.40%

In the past 12 months, Diaceutics has paid 143.00K in taxes.

Diaceutics EV to EBITDA ratio is 16.79, with an EV/FCF ratio of 71.63.

Diaceutics has £8.10M in cash and marketable securities with £2.09M in debt, giving a net cash position of £6.01M billion.

Gross margin is 67.81%, with operating margin of 0.69%, and net profit margin of 0.25%.

The average price target for Diaceutics is £215.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy